ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 763 filers reported holding ASTRAZENECA PLC in Q2 2021. The put-call ratio across all filers is 0.77 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,558 | -5.4% | 23 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $1,647 | +3.1% | 23 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $1,597 | +2.4% | 23 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $1,559 | -77.7% | 23 | -81.3% | 0.00% | -75.0% |
| Q3 2022 | $7,000 | -12.5% | 123 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $8,000 | 0.0% | 123 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $8,000 | +14.3% | 123 | 0.0% | 0.00% | +33.3% |
| Q4 2021 | $7,000 | 0.0% | 123 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $7,000 | +16.7% | 123 | +23.0% | 0.00% | 0.0% |
| Q2 2021 | $6,000 | +20.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $5,000 | -28.6% | 100 | -33.3% | 0.00% | -25.0% |
| Q4 2020 | $7,000 | -12.5% | 150 | 0.0% | 0.00% | -20.0% |
| Q3 2020 | $8,000 | 0.0% | 150 | 0.0% | 0.01% | -16.7% |
| Q2 2020 | $8,000 | +100.0% | 150 | +50.0% | 0.01% | +50.0% |
| Q1 2020 | $4,000 | -20.0% | 100 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $5,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |